Oxaliplatin Injection, USP, 50 mg/10mL and 100 mg/20mL

Athenex Pharmaceutical Division

Revision date : 2017-11-29

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
Health risk rating 1
Safety risk rating 1
Environmental risk rating 1

Note: Ingredients listed on restricted chemical lists

EC/CAS

7732-18-5

Name of the chemical

Water, distilled, conductivity or of similar purity H2O

Concentration

N/A

General Information

Revision date

2017-11-29

Product name

Oxaliplatin Injection, USP, 50 mg/10mL and 100 mg/20mL

Chemical name

cis-[(1 R,2 R)-1,2-cyclohexanediamine-N,N"] [oxalato(2-)- O,O"] platinum

Emergency telephone

855-273-0154

Icons in SDS

Company Information

company name

Athenex Pharmaceutical Division

GHS Information

Signal word

Oxaliplatin

Section 2

SECTION 2: Hazards identification

a)

2.1 Classification of the substance or mixture

Mutagenic, cytotoxic, neurotoxic and fetotoxic. The drug substance is a possible carcinogen and a severe eye irritant.

Signal word

Oxaliplatin injection is an antineoplastic agent and is Hazard statement(s), considered a Hazardous Drug per the NIOSH alert: Symbol(s), and/or Preventing Occupational Exposures to Antineoplastic and Precautionary Other Hazardous Drugs in Health Care Settings. Health care workers who prepare or administer hazardous drugs or who

Hazard statements

work in areas where these drugs are used should follow specific handling guidelines to prevent exposure to these agents in the air or on work surfaces, clothing, medical equipment, or patient urine or feces. See Section 8 for specific handling guidance from the NIOSH Alert for use in the health care setting. (c) Description of Anticipated signs of overexposure include nausea, vomiting, diarrhea, peripheral neurotoxicity (with cold sensitivity and rare laryngeal dysesthesias, sensation of difficulty with breathing or swallowing), and possible myelosuppression (low blood counts). Mucositis (sore mouth, or soreness of other mucous membranes) and transient elevation of liver enzymes have been observed. As with other platinum compounds allergic reactions have been observed. In therapeutic use, very rare anaphylactoid reactions (severe, possibly life-threatening allergic reactions) have been observed. (d) Unknown Acute N/A Toxicity:

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.